Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Odeon Capital Downgrades KeyCorp to Hold

Odeon Capital Downgrades KeyCorp to Hold

Odeon Capital analyst Dick Bove downgrades KeyCorp (NYSE:KEY) from Buy to Hold.

byBenzinga Newsdesk

March 13, 2023

1 minute read

Odeon Capital analyst Dick Bove downgrades KeyCorp (NYSE:KEY) from Buy to Hold.

News

PDS Biotech To Be Added To Russell 2000 And Russell 3000 Indexes Effective June 26, 2023

By Happy Mohamed

June 20, 8:23 AM

PDS Biotechnology Corp. (NASDAQ:PDSB), a clinical-stage company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, announced today its expected addition to the broad-market

PDSB

Cowen & Co. Maintains Market Perform on Emergent BioSolutions, Lowers Price Target to $29

By Benzinga Newsdesk

September 12, 9:55 AM

Cowen & Co. analyst Boris Peaker maintains Emergent BioSolutions (NYSE:EBS) with a Market Perform and lowers the price target from $30 to $29.

EBS

SVB Leerink Maintains Outperform on Pliant Therapeutics, Raises Price Target to $45

By Benzinga Newsdesk

January 24, 5:44 AM

SVB Leerink analyst Mike Kratky maintains Pliant Therapeutics (NASDAQ:PLRX) with a Outperform and raises the price target from $33 to $45.

PLRX

Analyst Ratings

Where Savers Value Village Stands With Analysts

By Benzinga Insights

November 10, 3:00 PM

Within the last quarter, Savers Value Village (NYSE:SVV) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent…

SVV

Odeon Capital Downgrades KeyCorp to Hold

Related Posts

PDS Biotech To Be Added To Russell 2000 And Russell 3000 Indexes Effective June 26, 2023

Cowen & Co. Maintains Market Perform on Emergent BioSolutions, Lowers Price Target to $29

SVB Leerink Maintains Outperform on Pliant Therapeutics, Raises Price Target to $45

Where Savers Value Village Stands With Analysts